Go Binky! Goldman Sachs Group Inc.’s David Kostin and well-know stock bull Ed Yardeni of Yardeni Research have also tempered their outlooks. But Deutsche Bank’s Binky Chadha is sticking with his call for the S&P 500 to soar to 7,000 by late December on hopes that Trump will scale back tariffs. “When the bear market pieces are everywhere, it will be a good time to flip back,” said veteran strategist Jim Paulsen, who thinks it’s unlikely the rout will escalate into a full-blown crash, though still sees more pain ahead. “What’s going to be a hell of a question is, who are the next leaders?” That is the question. I wish I knew the answer. If it's same old big tech we are bound to be disappointed in the outcome. Copper!
I don't tell the HF what to buy except for my special requests: I have asked for NTFLIX and SPOT, ERO & VVV. VVV~~
Stoney any thoughts? “ Ovarian Cancer Therapy Meets Main Goal in Phase 3 Study; Shares Jump MT Newswires· 21 mins ago 1min Corcept Therapeutics(CORT.US) 54.63098.530 -3.62% +80.36% Corcept Therapeutics (CORT) said Monday its phase 3 trial of relacorilant plus nab-paclitaxel to treat a type of ovarian cancer met its primary goal, sending shares up more than 90% in recent premarket trading activity. The company said the study showed a 30% reduction in the risk of disease progression for patients treated with relacorilant and nab-paclitaxel compared to those receiving nab-paclitaxel alone.”
Cramer backs away from market now. LOL. Where were you bubs when we needed you. Oh yea pushing Ai....
Huge need obviously Ovarian is very nasty. CORCEPT makes money. Has a PE what's not to like except today's price. They still have to get FDA ok...
“TrailerParkTed said: I can’t recommend MLGO but is it strong! The shorts are stuck unless MLGO dilutes. $17 holding.” $18.70 These stocks freak me out!